Interleukin la (IL-la), IL-2, IL-4, IL-6, gamma interferon (IFN-y), tumor necrosis factor alpha (TNF-c), and granulocyte macrophage colony-stimulating factor (GM-CSF) were tested for their abilities to alter the growth of Brucella abortus in BALB/c J774A.1 murine macrophages. IL-la, IL-4, IL-6, tumor necrosis factor alpha, and granulocyte macrophage-colony-stimulating factor had no consistent or significant effect on the growth of the avirulent B. abortus strain 19. In contrast, the addition of either IFN-y or IL-2 at 100 U/ml to the macrophage cultures resulted in a significant reduction in the number of intracellular bacteria that was not attributable to decreased infection rates. With IL-2, the reduction was most often apparent only during the first 24 h after infection, while inhibition with IFN-y was apparent throughout the culture period of 48 h. The addition of either IL-2 or IFN-y to macrophage cultures also resulted in reduced intracellular CFU of the virulent B. abortus strain 2308 and the attenuated rough mutant B. abortus strain RB51. Inhibition of intracellular growth was not augmented by combinations of cytokines. Additional studies with IFN-'y and IL-2 indicated that they could mediate the inhibition of intracellular growth of B. abortus in resident and thioglycolate broth-induced BALB/c peritoneal macrophages and in splenic macrophages. IFN-y also inhibited bacterial growth when added after infection of the macrophages, although the magnitude of the antibrucellae effects was less than that when it was added before infection. Furthermore, the maximal inhibitory effect was sustained only when IFN-y remained in the cultures after infection of the macrophages.
Brucella are gram-negative, facultative intracellular bacteria which replicate in host mononuclear phagocytes, causing chronic infections in humans as well as in agricultural animals, particularly cattle, sheep, goats, and pigs (32, 47) . Infections in humans are almost exclusively due to zoonosis, either through direct contact with infected animals or from contaminated dairy products (33) . Thus, the control of br.;cellosis in animals is necessary for its control in humans. Inbred strains of mice which differ in their capacities to prevent chronic infections with Brucella abortus have been previously identified and employed to evaluate the nature of innate resistali2e as well as that of acquired immunity (21, 28) . When B. abortus 19, an attenuated vaccine strain, is used to infect BALB/c mice, the mice clear the infection (21, 28) , whereas when the mice are infected with B. abortus 2308, a virulent field isolate, a chronic infection is established (28) . This pattern of resistance and susceptibility to virulent and avirulent strains of B. abortus in BALB/c mice is similar to that observed following infection of cattle, making them a good model for bovine brucellosis (28) .
By using the murine model, it has been previously established that acquired immunity to B. abortus is mediated both by antibodies, predominantly to lipopolysaccharide (LPS) molecules (2, 28) , and by CD4 and CD8 T cells (1, 35 ). An adoptive transfer of either population of T cells to naive mice results in similar levels of protection (1) . While the mechanisms of T-cell-mediated immunity have not been elucidated, it has been previously demonstrated with both bovine (19) and guinea pig (7) macrophages that virulent strains of B. abortus have increased survival and growth in macrophages compared with those of avirulent strains or rough mutants. Cell-mediated immunity to brucellosis, therefore, is likely to include the production of cytokines which acti-* Corresponding author.
vate macrophages for antibrucella activities. To elucidate the role of cytokines in protective, cell-mediated immunity to B. abortus, we investigated the abilities of a panel of seven cytokines to either inhibit or facilitate the intracellular survival and growth of B. abortus in macrophages.
The literature concerning macrophage activation and induction of antimicrobial mechanisms by cytokines is complex, partially as a result of the multiple pathways used for microbial killing. Gamma interferon (IFN-y) is capable of upregulating three major pathways described for microbial killing, i.e., the production of reactive oxygen intermediates (31) , the production of nitrogen intermediates (44) , and the induction of indolamine 2,3-dioxygenase to catabolize tryptophan (see reference 8) , and it has been shown to induce antimicrobial activities against a variety of intracellular parasites, including Mycobacterium bovis (16) , Mycobacterium tuberculosis (16, 41) , Leishmania major (15, 17, 34) , and Listeria monocytogenes (38) . The abilities of other cytokines to activate macrophage antimicrobial activities are more variable. Tumor necrosis factor (TNF) can elevate H202 production and nitrite release from IFN-y-phorbol myristate acetate-stimulated macrophages (14) , and TNFtreated macrophages inhibit the survival or growth of Mycobacterium lepraemurium (10) and Mycobacterium avium (5, 12) . TNF also synergizes with IFN--y to activate macrophages to kill L. major (6, 26) . Granulocyte macrophage colony-stimulating factor (GM-CSF) increases the production of H202 (14) by macrophages and activates macrophages to inhibit the growth of Trypanosoma cruzi (39) and to kill Leishmania donovani (46) . GM-CSF also synergizes with IFN-y to activate macrophages for resistance to infection by L. major (3). Interleukin 2 (IL-2) synergizes with TNF or LPS to stimulate production of reactive oxygen intermediates by macrophages (5, 45) and, in conjunction with IFN-,y, activates macrophages to inhibit infection by L. major (3) . IL-4 synergizes with IFN-,y to activate macro-phages to resist infection by L. major (3) . IL-1 plays a role in macrophage activation (9, 37) and, when administered to mice, prevents chronic infection by B. abornus (48) . In contrast, some cytokines, namely, IL-1, IL-3, IL-6, and M-CSF, have been shown previously to facilitate the growth of M. avium in human macrophages (11, 12, 43 abortus to macrophages and then incubated at 37°C for 1 h and 50 min. To ensure that macrophages which became less adherent after infection or cytokine treatments were not lost, macrophage cultures were centrifuged at 2,800 x g between treatments which involved the removal of supematant.
Following the 2-h infection period, the majority of extracellular bacteria were removed by washing the macrophage cultures twice with medium containing antibiotics. To do this, 0.15 ml of RPMI 1640 containing 120 ,ug of gentamicin per ml (GIBCO) and 71.5 ,ug of streptomycin sulfate per ml (GIBCO) was added to each well by allowing the medium to run down the side of the well. Since B. abortus is a facultative intracellular bacteria and since our initial experiments indicated that it proliferated in c-RPMI, it was necessary to add antibiotics to the macrophage cultures. A number of trials were performed to determine the concentration of antibiotics and the time required to kill extracellular brucellae. We found a combination of gentamicin and streptomycin sulfate which killed extracellular brucellae in 1 h. To ensure that extracellular brucellae were killed following this treatment, at 1, 3, 24, and 48 h after the addition of antibiotics, 150 tl of supernatant was collected from each infected macrophage culture following centrifugation of the microtiter plates at 200 x g to pellet macrophages but not bacteria (determined in trials ascertaining the differential pelleting forces required for macrophages and bacteria). The above supernatants were then centrifuged at 12,000 x g in a minifuge to pellet bacteria. The pelleted bacteria were washed with antibiotic-free medium and plated on agar plates to determine CFU. The supernatants of macrophage cultures contained 0 to 3 CFU (less than 0.01% of the intracellular CFU measured at that time). Microscopic observations indicated that macrophages remain adherent dur-VOL. 61, 1993 ing this gentle washing procedure. Extracellular killed bacteria were removed from the cultures to minimize their potentially confounding effect on the macrophage activation with cytokines. Our concern for the effect of extracellular bacteria arises from the fact that B. abortus contains LPS, and Enterobacteriaceae LPS, at least, is a potent trigger for activated macrophages. To kill any residual bacteria which were not removed during the wash procedure and any additional extracellular bacteria which were released as a result of macrophage deaths, macrophage cultures were incubated overnight in c-RPMI with the same concentration of antibiotics. Fresh cytokines were also added to the macrophage cultures following the wash procedure. After the overnight incubation, the macrophage cultures to be assessed after 24 h (1 day) were treated as described below, whereas the macrophage cultures which were to be continued for 2 or 4 days were washed at this time to remove the high concentration of antibiotics and were provided with c-RPMI containing fresh cytokines and 60 ,ug of gentamicin per ml. Microscopic evaluations of the macrophage cultures were made to ensure that cells were not lost during the wash procedure. Initial experiments also evaluated the viabilities of J774A.1 and peritoneal macrophages, which were maintained in these cultures, at various times after infection by trypan blue exclusion of cells.
Microscopic evaluation of infected macrophages. To determine intracellular infection of macrophages, 105 macrophages per well were plated on round coverslips in 24-well plates for light-microscopic evaluation. Following infection of macrophages with B. abortus as described for the microwell cultures and after incubation for various periods of time, macrophages were washed twice with PBS, fixed with methanol, and stained with Giemsa stain.
Macrophages were plated in 24-well plates at 105 per well, infected, and evaluated by transmission electron microscopy after a 48-h incubation period. To prepare them for electron microscopy, macrophages were washed twice with RPMI and removed by gentle scraping with a rubber policeman. The cells were fixed by standard techniques with 1% glutaraldehyde (Sigma) in 0.1 M phosphate buffer for 1 h at 4°C and then embedded in 1% agarose. The cell-containing agarose was cut into 1-mm3 cubes, postfixed with 1% osmium tetroxide in phosphate buffer on ice for 1 h, and embedded in Spurr resin (Sigma). Thin sections were cut and viewed with a Philips electron microscope.
Incubation times and inhibition by IFN-'y. To evaluated. Macrophages were preincubated with IFN--y for 24 h before infection, as described in the preceding sections. In one set of replicate cultures, IFN--y was added back after infection, while in another set it was not. Control cultures which never received IFN-y were established in parallel. All cultures were infected simultaneously, and all other manipulations were the same as described above.
Combinations of cytokines. The J774A.1 macrophage cell line or thioglycolate-induced peritoneal macrophages were incubated for 96 h with IFN-y at either 3 U/ml (suboptimal concentration) or 100 U/ml (optimal concentration). Other cytokines, which were evaluated for their abilities to enhance or diminish the inhibition induced by IFN--y, were then added to the macrophage cultures, and the cultures were incubated for a further 24 h before infection. Further procedures were as described above, except that the combinations of cytokines were added back after infection. In experiments which evaluated the effect of combining IL-2 and TNF, the cytokines were added together 24 h before infection as well as after infection.
Determination of the number of intracellular bacteria. After infection for 1, 2, or 4 days, the adherent macrophages were washed three times by adding 0.15 ml of PBS to the culture wells, removing it, and then adding 100 ,ul of 0.1% deoxycholate (Sigma) in PBS to each well in a manner similar to that of a method described previously (18) . After being incubated at room temperature for 5 min, the cell lysates from triplicate wells were pooled. Following lysis of the macrophages, the contents of the wells were resuspended, the replicate cultures pooled and immediately centrifuged at 12,000 x g for 5 min in microcentrifuge tubes to pellet brucellae, the supematant was discarded, and the bacteria were resuspended in 0. (Fig. 4 to 7) .
RESULTS
Establishment of the macrophage infection assay. Lightmicroscopic evaluation of the stained infected cells indicated that 3 h following infection, approximately 30 to 40% of the J774A.1 macrophages were infected. At this time, on a per population basis, there is an approximate 3 bacteria/macrophage ratio. To ensure that the Giemsa-stained whole-cell preparations were not revealing brucellae that adhered to the macrophages, thin sections of the infected macrophage preparations and control macrophage preparations were observed by electron microscopy. Our observations (Fig. 1) indicated that the brucellae were indeed intracellular. At 48 h after infection, the cytoplasm of infected macrophages was heavily loaded with brucellae. Macrophage viability at 48 h after infection was between 80 and 98% in various experiments.
Since brucellae grew very well in c-RPMI, quickly overwhelming the cultures and killing the macrophages, it was necessary to add antibiotics to the macrophage cultures. Gentamicin has a moderate ability to enter macrophages (27) . While we cannot be certain that gentamicin in the cultures did not accumulate in the macrophages over time, thereby affecting the number of intracellular bacteria, we found that the number of intracellular B. abortus organisms increased in macrophages cultured in antibiotic-containing medium between 12 and 48 h (Fig. 2A) . The doubling time of intracellular brucellae during this interval had a mean of 10.3 h on the basis of seven experiments, while the doubling time for log-phase extracellular brucellae grown in c-RPMI was 2 to 2.5 h. To compensate for the potential inhibitory effects of antibiotics on intracellular growth, all experimental results for macrophage cultures treated with cytokines were expressed relative to those for control macrophage cultures which did not receive cytokines but for which experiments were conducted in parallel.
Growth of B. abortus in macrophages. Our results showed that during the first 12 h after infection of J774A.1 macrophages ( Fig. 2A) , the number of intracellular brucellae decreased. Following this, the number of intracellular brucellae then increased until 2 days (48 h) after infection (Fig.  2) , but by 4 days the number of intracellular bacteria had decreased (Fig. 2B) . The number of intracellular brucellae did not change radically between 2 and 3 days after infection in other experiments (data not shown). The decrease in intracellular bacteria may represent the deaths of the infected macrophages and the exposure of brucellae to extracellular antibiotic killing, as previously shown by others following infection of Vero cells with B. abortus (13) . Thus, our results, which evaluated the effects of cytokines on intracellular growth of B. abortus, were confined to evaluations during the first 48 exponential increase in the number of intracellular bacteria was measured with non-cytokine-treated macrophages. Effect of cytokines on intracellular survival and growth ofB. abortus. Seven cytokines, IL-la, IL-2, IL-4, IL-6, TNF, GM-CSF, and IFN--y, were tested for their abilities to alter the number of intracellular B. abortus 19 organisms. In all experiments performed, the number of intracellular brucellae was indicated relative to that in the control culture (no cytokines added) and expressed as relative CFU. Relative CFU was calculated for each experiment, and the means of replicate experiments are expressed (see the legend to Fig.  3) . The results indicated that IL-la, IL-4, IL-6, GM-CSF, and TNF-ot had no significant and/or consistent effect on the number of bacteria in macrophages during the first 2 days following infection (Fig. 3) relative to that in control macrophage cultures which had no exogenous cytokines added.
The addition of IL-2 to macrophage cultures (Fig. 3 ) resulted in fewer intracellular bacteria 24 h after infection relative to those in control cultures (P < 0.01). At 48 h after infection, the number of intracellular bacteria in cultures containing IL-2 was often not significantly different from that in the control cultures. Macrophage cultures containing IFN-y also consistently had fewer bacteria than control cultures at 24 and 48 h after infection ( Fig. 3 ; P < 0.05 for both time points). At 2 days after infection, the number of bacteria in macrophage cultures containing 100 U of IFN--y per ml were fewer by log1o 1.13 to 2.63 (92.6 to >99.4% reduction in bacterial CFU for seven experiments performed) than those in control cultures. The decrease by IFN-,y or IL-2 could not be accounted for by a lower rate of infection. While in some experiments, the number of intracellular bacteria following infection was lower in cytokinetreated macrophages, overall there was not a consistent decrease in the infection rate of IL-2-or IFN--y-treated macrophages. Representative experiments are presented to illustrate the effects of cytokine treatment at several time points (Fig. 4) . While variation occurred among experiments, the decrease in intracellular brucellae could be attributed to both brucellacidal and brucellastatic activity.
Neutralization of IFN-y. Since IFN-y had the most profound and sustained effect on the intracellular growth of brucellae, additional experiments were performed to ensure that the effect was due to the cytokine and not to a contaminant of the recombinant preparation. Hamster anti- TNF-a (l), 1,000, 2; IL-la (E), 100, 2; IL-2 (=), 100, 6; IFN--y ( ml ), 100, 7.
INFECT. IMMUN. abortus strains has previously been correlated with their abilities to survive in phagocytes (7, 19) . Here, we compared the abilities of IFN--y-and IL-2-treated macrophages to regulate the intracellular growth of a virulent smooth strain of B. abortus, i.e., the virulent field isolate strain 2308, and that of its rough mutant, strain RB51. We found that activation of macrophages with either cytokine resulted in decreases in the intracellular brucellae of both strains comparable to that obtained in experiments which employed strain 19 ( Fig. 5) . Activation of various macrophage populations with IFN-y. To ensure that the antibrucellae effects mediated by IL-2 and IFN-y with the J774A.1 macrophage cell line were applicable to tissue macrophages, they were tested for their abilities to increase antibrucellae activities in ex vivo BALB/c macrophage populations (Fig. 6) . The macrophage populations included thioglycolate broth-induced peritoneal macrophages, resident peritoneal macrophages, and splenic macrophages. B. abortus 19 grew intracellularly in all three macrophage populations, although the relative numbers of brucellae in each macrophage population differed (Fig. 6) . However, the addition of IFN--y to the cultures resulted in fewer intracellular brucellae in all three macrophage populations (Fig. 6) , and the addition of IL-2 resulted in fewer intracellular brucellae in the induced peritoneal macrophages evaluated (Fig. 4) .
Evaluation of synergistic effects of cytokines on intracellular growth of bacteria. It has been previously reported that the activation of macrophages by IFN--y can be augmented by a number of other cytokines, including TNF (6), IL-2 (4), IL-1 (9), GM-CSF, and IL-4 (3). In addition, TNF has been shown to synergize with IL-2 for macrophage activation (5) . Here, we tested six recombinant cytokines for their abilities to enhance the inhibition of B. abortus growth which was incurred by IFN-y at optimal and suboptimal concentrations of IFN--y. Experiments were also performed to determine whether the inhibitory effects obtained with IL-2 could be enhanced by the addition of exogenous TNF.
To determine the optimal and suboptimal concentrations of IFN--y for mediation of its inhibitory effect on B. abornus growth, IFN--y was tested over a range of concentrations. The results of this experiment are depicted in Fig. 7 . Significant inhibition of intracellular bacterial growth occurred in cultures of infected J774A.1 macrophages containing either 10 or 100 U of IFN--y per ml (P < 0.01), although the level of inhibition was clearly less with 10 than with 100 U/ml (Fig. 7) . IFN-y at 1 U/ml resulted in slight inhibition. Concentrations below 1 U/ml never significantly decreased the growth of B. aborts. Additional experiments showed that the level of inhibition was not increased when IFN-y was added at 1,000 U/ml compared with inhibition at 100 U/ml (data not shown). Bacterial CFU in the cultures were assessed at 24 and 48 h after infection and are represented as mean log10 CFU. The SD indicated represents the experimental variation incurred in determining the CFU from replicate plates and serial dilutions. 1 , IFN--y at 1 U/ml; l, IFN at 10 U/ml; FOi, control medium.
When the other cytokines tested were added to macrophage cultures treated with IFN--y, none of them consistently augmented the ability of IFN-y to inhibit the intracellular growth of B. aborus in J774A.1 macrophages and induced peritoneal macrophages when IFN-y was added at optimal (100 U/ml) and suboptimal (3 U/ml) concentrations (Table 1) . Furthermore, they did not diminish the inhibitory effect mediated by IFN-y. In cocytokine experiments involving (Fig. 8A) , after infection only (Fig. 8B) , or before infection only (Fig. 8C) . In all experiments, fewer intracellular brucellae were recovered from IFN--y-treated macrophages than from the control medium. Differences were significant (P < 0.01) even when the IFN--y was added at the time of or after infection of macrophages ( Fig. 8A and B) . We also evaluated whether it was necessary for IFN-y to be present in the macrophage cultures after infection with B. abortus in order to inhibit the intracellular growth of the bacteria. When macrophages were incubated with IFN-y for 24 h before infection but deprived of it after infection, the reduction of bacteria was less than when the IFN--y remained in the culture wells (Fig. 8C) .
DISCUSSION
This study sought to further our understanding of cellular immunity to brucella infections by identifying cytokines which altered the ability of B. abortus to survive and replicate in host macrophages. The cytokines evaluated were those which had been previously shown to have an effect on the abilities of other intracellular pathogens to infect, survive, or replicate in murine macrophages or human monocytes (3, 5, 6, 10, 12, 15-17, 26, 34, 38, 39, 41, 43, 45, 46) . The results of the present study indicate that, of the seven recombinant cytokines evaluated, only the additions of IFN--y and IL-2 to macrophage cultures resulted in a reduction in the number of intracellular B. abortus organisms in BALB/c macrophages and that none of the other cytokines evaluated augmented or inhibited these effects. The inhibitory effect by IL-2 was most often evident only during the first 24 h after infection, even though the culture medium was supplemented with fresh IL-2 at 24 h after infection. In contrast, the inhibition mediated by IFN--y was consistently apparent throughout the 48-h culture period. IL-2 and IFN--y may evoke different antimicrobial mechanisms, thus accounting for the different temporal effects. Alternatively, IL-2 may downregulate macrophage activation after 24 h. Studies to determine the pathway(s) of IL-2-experimental variation incurred in determining the CFU from replicate plates and serial dilutions. (A) J774A.1 macrophages were plated into 96-well plates 4 days before being infected, and 100 U of IFN--y per ml was added at various times before infection as indicated or at the time of infection only (0). The CFU in the macrophages were assessed 48 h after infection. Med, control medium. (B) J774A.1 macrophages received IFN--y at 100 U/ml either 24 h before infection (-24) as well as after infection or only 2 or 24 h after infection (+2 and +24, respectively). CFU were assessed 48 h after infection. Med, control medium. (C) J774A.1 macrophages were incubated with IFN-y 24 h before being infected, after which IFN--y was either added back ( M ) or not added back ( M ). CFU were assessed 24 and 48 h after infection. EL1, control medium.
and IFN-y-mediated antibrucella effects are under way.
Although it could be argued that the effects which we have observed with IFN-y and IL-2 occur as a result of the cytokines increasing uptakes of antibiotics by macrophages, we feel that this is an unlikely explanation. Recent studies have shown that the antibrucella effects by IFN--y-activated macrophages can be blocked by the addition of superoxide dismutase and catalase (22) . Since more brucellae were recovered from IFN--y-activated macrophage cultures which had also received inhibitors of reactive oxygen intermediates, it is unlikely that the IFN--y-mediated inhibition of brucella growth is a spurious impression resulting from either increased accumulation of antibiotics following IFN-y treatments or from enhanced growth of brucellae in the treated macrophages which ultimately resulted in lysis of "overloaded" macrophages. Furthermore, while evaluations performed with the J774A.1 cell line are complicated by the fact that the cells can continue to growth after infection, the fact that we observed similar effects with IFN--y and IL-2 on tissue macrophages indicates that the results are not due to an erroneous impression resulting from the inhibition of growth of J774A.1 cells by the cytokines, thereby providing fewer target cells for infection.
While IFN--y alone has been previously shown to be sufficient for activation of macrophages for the antimicrobial activities of a number of intracellular parasites (15-17, 34, 41) , there is less precedent for IL-2 to mediate this role. IL-2 has been reported, however, to act as a cofactor for macrophage activation (3) (4) (5) 45) . In our study, no other factors were required for the induction of brucellastatic activity. Similarly, IFN--y-mediated inhibition of B. abortus growth was not augmented by cytokines previously shown elsewhere to cooperate with IFN--y for induction of macrophage antimicrobial or tumoricidal activity (3, 6, 9, 14, 20, 26) . The unique nature of our results may be due to the source of macrophages (i.e., a different mouse strain), or they may indicate that IL-2 and IFN--y limit intracellular growth of B. abortus by mechanisms which differ from those operative in the studies reported. In addition, brucella has LPS in its cell envelope and, therefore, may alter the requirements of cytokine-induced macrophage activation. Enterobactenaceae LPS is a potent cofactor for activation of macrophages. While B. abortus LPS differs significantly from Enterobacteriaceae LPS in terms of biological activity (29, 30) , we cannot discount its contribution to macrophage activation in our system.
In this study, we employed antibody-opsonized brucellae for two reasons. First, opsonization facilitated the infection of macrophages, and second, in vivo infection with brucella stimulates antibody production. Thus, it is likely that macrophages are phagocytosing opsonized brucellae in natural infections following the expression of acquired immunity.
While IFN-y has been previously reported to inhibit immunoglobulin G-mediated phagocytosis (40) , the mechanism of antimicrobial activity measured here is not inhibition of infection. Macrophages either cultured in tissue culture medium alone or precultured for 24 h in medium which contained 100 U of IFN--y per ml had equal numbers of intracellular brucellae following the infection period. Furthermore, we found that IFN--y was effective at inhibiting the intracellular growth of B. abortus even when it was added to macrophage cultures only after infection and that IFN--y activates macrophages to inhibit replication of brucellae following infection of macrophages with nonopsonized brucellae as well (22a (25) . There is evidence from other systems that IFN--y can protect nonphagocytic cells from microbial parasitism, as shown for infection of fibroblasts by Toxoplasma gondii through induction of indolamine 2,3-dioxygenase activity (36 
